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The need for precise and flexible synthetic methodology to
underpin modern research in chemical biology and materials
science has fuelled a resurgence of interest in Huisgen 1,3-
dipolar cycloaddition chemistry. Of late, the in vogue chemis-
try for the assembly of complex biological molecules and spe-
cialist materials has been the copper-catalysed azide alkyne
cycloaddition (CuAAC) reaction. However, in certain circum-
stances aversion to the copper catalyst flaws this approach
and alternatives have been sought. Click chemistry has de-
1. Introduction
Transformations classified as “click reactions”[1] en-
compass those allowing rapid and reliable creation of di-
verse chemical entities simply by joining molecular pieces
as easily as one might click a buckle. To be in this illustrious
club, reactions must be wide in scope, easily performed un-
der mild conditions, insensitive to oxygen and water and
proceed in a benign solvent or under solvent-free condi-
tions. They must use easily accessible reagents and display
orthogonality with other common reactants. The reactions
ought to be spontaneous, with a thermodynamic driving
force greater than 20 kcalmol–1 and result in almost com-
plete conversion of reactants to a single product without
the need for extensive purification.
During the last decade these privileged reactions have be-
come valued in industry and academia; applications trans-
verse biomedical research, drug design, biotechnology and
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veloped beyond the original triazole-forming trick and azides
are no longer the only dipoles pursued as click cycloaddition
partners. This article reviews some of the complications of
the CuAAC reaction and evaluates the potential of nitrile ox-
ide/alkyne cycloaddition (NOAC) as a covalent conjugation
tool. With a focus on applications in nucleic acid chemistry
and materials science it presents the case for a prominent
position for nitrile oxides in the catalyst-free bioconjugation
toolbox.
materials science. Publications have increased exponentially,
totalling about 5000 to date, including almost 200 review
articles and a specialist monograph.[2] Entire issues of
QSAR & Combinatorial Chemistry [2007, 26 (11–12)], Mac-
romolecular Rapid Communications [2008, 29 (12–13)] and
Chemical Society Reviews [2010, 39 (4)] have been dedicated
to click chemistry; most recently Accounts of Chemical Re-
search has published a themed issue on bioorthogonal
chemistry [2011, 44 (9)].
2. The Click Toolbox
The click toolbox is ever expanding and practitioners can
choose their tool to reflect a preference for selectivity or
sensitivity. Favoured reactions include nucleophilic opening
of spring-loaded electrophiles[3a] and nucleophilic addition
to carbonyl substrates yielding oximes and hydrazones,[3b] a
variety of thiol chemistries[4] and cycloaddition reactions
including the Diels–Alder reaction.[5] However, the wide-
spread adoption of the copper(I)-catalysed azide/alkyne cy-
cloaddition – the so-called CuAAC reaction – has made it
almost synonymous with the term “click chemistry”.
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3. The Gold Standard CuAAC Reaction
In its modern genesis,[1,6] the triazole-forming CuAAC
reaction, discovered at the end of the 19th century[7] and
studied extensively by Huisgen[8] in the 1960s, has been ut-
terly transformed. It is now known that the poor kinetics
and selectivity of the classic thermal reaction can be over-
come by the addition of a catalytic amount of copper. The
CuAAC reaction is the most championed click reaction,
with applications in supramolecular[9] materials[10] and
polymer chemistry.[11] It has also been central to the synthe-
sis of drug candidates[12] and nucleoside analogues;[13] other
bioinspired applications include protein engineering,[2] bio-
logical imaging[14] and biomimetic modelling.[15]
3.1. Drawbacks to Copper-Catalysed Azide/Alkyne
Cycloadditions
Despite its status as the quintessential click reaction, the
CuAAC is not ubiquitously attractive.[16] It requires op-
timisation of a number of reagents and the need for the
Cu(1) catalyst can be limiting. Toxicity is problematic for
reactivity in living systems, in tissue engineering applica-
tions and in development of therapeutics.[17] The cytotoxic
copper ions[18] can cause oxidative damage including DNA
degradation and polysaccharide or protein denaturation.[19]
Catalytic copper ions are incompatible with some synthetic
targets, such as those incorporating chelating or Fischer
carbene moieties.[20] In other cases, product entrapment of
the catalyst ions has necessitated the use of stoichiometric
amounts of copper and has resulted in polymeric materials
with inferior properties to those formed by classical thermal
polymerisation methods.[21] Trace copper is especially prob-
lematic in the pharmaceutical sector, where levels must re-
main below 15 ppm.[22] Catalyst impurities impact nega-
tively on enzyme-linked immunosorbent assays (ELIZA),
on the biochemical properties of labelled phages and the
luminescence characteristics of quantum-dot-functionalised
biomolecules.[23]
3.2. General Solutions to the Problems of Residual Copper
A palette of tools designed to circumvent problems asso-
ciated with the presence of residual copper is emerging. In
limited circumstances the reactions might proceed satisfac-
torily in the absence of copper (e.g. with “activated” sub-
strates[24]) or with the application of specialised experimen-
tal techniques (e.g. microcontact printing[25]). However,
more general solutions are desirable. One approach involves
extensive washing to eliminate residual copper ions;[26] an-
other relies on catalyst remediation (e.g., sequestration by
oxide-capped metallic iron nanoparticles, FexOy@Fe).[22]
Alternatively, judicious choice of copper source can facili-
tate removal by simple filtration [e.g., CuI-zeolites, bench-
stable copper-in-charcoal or copper nitride (Cu3N) nano-
particles supported on a superparamagnetic silica micro-
sphere].[27] Still other approaches rely on catalyst formula-
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tions free of cytotoxicity; practical solutions include con-
ducting the reaction under air-free conditions or with CuI-
stabilizing ligands (e.g., TBTA, BTTES or BTTAA).[28] The
last two, tris(triazolylmethyl)amines, are especially attract-
ive; they confer improved kinetics and bio-benign status on
the CuAAC reaction. Finally, “ligandless” click ligation or
labelling of unprotected RNA substrates has been facili-
tated by judicious choice of reaction solvent or alkyne part-
ner.[29]
3.3. Ruthenium as a Replacement for the Copper Catalyst
Ruthenium-catalysed azide/alkyne cycloadditions
(RuAACs), with regiochemical complementarity to the Cu-
promoted version have been developed[27b,30] (Scheme 1).
Several RuII complexes are catalytically active, and whilst
Cp*RuCl(PPh3)2 is the most widely adopted the nature of
the reacting azide informs the choice of catalyst.[31] In some
instances sluggish reactivity can be overcome by microwave
irradiation.[31b] The reaction is compatible with both ter-
minal and internal alkynes, although with the latter there
can be some compromise in regioselectivity.[30b,30c] Applica-
tions have been reported in materials[32] and medicinal
chemistry,[33] as well as in the preparation of nucleoside and
sugar derivatives, peptide surrogates and aminoacyl-tRNA
analogues.[34]
Scheme 1. Catalyst-controlled regioselective cycloadditions of az-
ides and terminal alkynes: i) Cp*RuCl(PPh3)2, PhH, reflux;[30b]
ii) sodium ascorbate, CuSO4, tBuOH, H2O, room temp.
3.4. Alkynes with Enhanced Reactivities – SPAAC
The poor kinetics of the CuAAC reaction at the concen-
trations desirable for bioconjugation have been addressed
by the development of strain-promoted azide/alkyne cyclo-
addition (SPAAC) chemistry. The significant reduction in
the activation barrier makes the requirement for a catalyst
redundant and, depending on the application, SPAAC reac-
tions can compete with the best CuAAC protocols.[23b] Nu-
merous cyclooctyne probes have been developed (Figure 1).
Incremental improvements on first-generation cyclooc-
tynes[23b,35] have yielded azacyclooctynes with enhanced
aqueous solubilities, as well as α-fluorinated and α,α-difluo-
rinated versions with improved kinetics.[20a,36] Diarylcy-
clooctynes, generated by classical or photochemical ap-
proaches,[37] their aza analogues [azadibenzocyclooctynes
(ADIBOs)],[38] including some carrying fluorescent or ra-
dio-reporting tags,[39] and the highly sensitive biarylazacy-
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clooctynones (BARACs)[40] all show enhanced reactivities
allowing reactions to occur within minutes rather than
hours. The superior kinetics of these reagents are important
in living systems in which reactivity must be faster than
metabolic probe elimination. In spite of its obvious attrac-
tions the SPAAC reaction carries a penalty of poor regiose-
lectivity[38b] and recent in vivo studies revealed that difluo-
rooctyne-based (DIFO-based) probes bind nonspecifically
to mouse serum albumin, presumably through formation of
covalent bonds between cysteine residues and the cyclooc-
tyne.[36d]
Figure 1. Representative cyclooctyne partners in SPAAC reactions.
4. Nitrile Oxides (and Nitrones) – Dipoles of
Enhanced Reactivity
The utility of dipoles other than azides has progressed
click chemistry beyond the triazole conjugating tool. We
and others have focused on nitrile oxide and nitrone cyclo-
additions; the ensuing cycloadducts – isoxazoles and their
partially saturated analogues – are, like the triazole nucleus,
an important class of heterocycle. The potential issue of
dipole instability, manifest in nitrile oxide dimerisation or
in nucleophile trapping,[41] is minimised by in situ genera-
tion and by judicious choice of reacting partner. The isox-
azole-generating nitrile oxide-alkyne cycloaddition (NOAC)
has many attractions:
Firstly, there is the ease and range of procedures available
for dipole formation from oxime substrates by direct or in-
direct oxidative methods, or from nitro precursors in the
presence of aryl isocyanates.[42]
Secondly, there are the attractive kinetics. The NOAC is
estimated theoretically, and observed experimentally[43] to
have more attractive kinetics than similar azide cycload-
ditions.
Thirdly, there is regioselectivity. Reactions of nitrile ox-
ides with monosubstituted alkynes lead regioselectively to
3,5-disubstituted adducts.[44]
Fourthly, there is synthetic utility. Despite its status as a
rather stable aromatic moiety the isoxazole nucleus masks a
variety of functionalities potentially valuable in subsequent
manipulations.[45] In addition to agrochemical applications,
isoxazole derivatives are valued pharmacophores. Present in
many natural and synthetic bioactive compounds, including
ibotenic acid and the COX-2 inhibitor valdecoxib, the isox-
azole system is hydrolytically stable. It shares the isosteric
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character of amide and ester bonds and has potential for
π-stacking and H-bonding, and so it has many possible
modes of action with biological molecules.[46]
Finally, in contrast to azides, there are only limited issues
relating to health and safety in the handling of the di-
pole.[47]
4.1. Catalyst-Promoted Cycloadditions between Alkynes and
Nitrile Oxides/Nitrones
Most nitrile oxide cycloadditions are catalyst-free, but re-
giocomplementary control has been demonstrated in the
presence of a copper,[48] an N-heterocyclic carbene
(NCH)[49] or a ruthenium catalyst.[50] Both the copper- and
the carbene-mediated reactions promote formation of 3,5-
disubstituted isoxazoles, whereas ruthenium catalysis fa-
vours 3,4-disubstituted ones (Scheme 2). Active copper(I)
catalysts have been obtained from copper(II) sulfate either
by ascorbate reduction or by comproportionation with cop-
per metal. Nitrile oxide generation involved either base
treatment of the desired hydroxamoyl chloride or reaction
between the parent oximes and either chloramine-T or NCS
and base. The reactions, predicted by computational models
to be much faster than with similar azides, do indeed pro-
ceed with remarkable acceleration. The catalysed reactions
have been shown to be tolerant of a number of functional
groups, although to date the conjugated oestradiol in Fig-
ure 2 remains the only bioinspired example.
Scheme 2. Catalyst-controlled regioselective cycloaddition reac-
tions between nitrile oxides and terminal alkynes. Nitrile oxides
generated in situ either from aldoximes by treatment with chlora-
mine-T[48] or through action of base on imidoyl chlorides
[RC(Cl)=NOH].[49,50]
Figure 2. Oestradiol conjugate prepared by Cu(1)-promoted nitrile
oxide/alkyne cycloaddition.[48a]
Reactions between nitrones and terminal alkynes have
limited synthetic appeal, but depending on their substitu-
tion patterns the resulting Δ4-isoxazolines are susceptible to
a variety of decomposition behaviour patterns.[51] Neither
are the CuI-catalysed reactions useful for generating isox-
azoline-linked conjugates; under click conditions the ini-
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tially formed cycloadducts undergo immediate collapse to
monocyclic β-lactams through Kinugasa-type reactions; see
Eq. (1).[52]
(1)
5. Bioinspired Syntheses Based on Catalyst-Free
Cycloadditions between Nitrile Oxides/Nitrones
and Terminal Alkynes
5.1. Nucleoside Analogues
Nitrile oxide/alkyne cycloaddition (NOAC) chemistry is
central to the synthesis of a number of bioinspired com-
pounds, including steroid and sugar conjugates, with in situ
generation of active dipoles from oximes, hydroxamoyl
chlorides or nitro compounds.[53] This field is dominated,
however, by the antiviral and anticancer potential of isox-
azole nucleoside analogues. Nitrile oxide approaches to nu-
cleoside derivatives with the nucleoside tagged either with
the dipolarophile or with the dipole precursor have been
demonstrated; both nucleobase- and ribose-modified ox-
imes have served as nitrile oxide precursors,[44,54] whereas
alkyne functionalities have more commonly been placed on
the base than on the sugar.[13,55] In the reports to date, Na-
OCl alone, NaOCl with NEt3, or NCS/NBS with NEt3 have
most frequently been selected as dipole generating agents,
although commercial bleach[55b] and hypervalent iodine rea-
gents such as PhI(OCOCF3)2 (PIFA)[56] present other op-
tions. PIFA, suited to generation of both nucleoside and
peptide conjugates, has reasonable functional group toler-
ance and examples of nucleoside analogues generated by
this methodology are illustrated in Figure 3.[56] In one re-
cent example a solid-phase approach was demonstrated,[13]
though more generally the cycloadditions are reported in
solution with THF or CH2Cl2 as reaction solvent.
Conjugation in aqueous media is highly desirable for bi-
oapplications; accordingly, the preparation of modified nu-
cleosides by NOAC induced by chloramine-T is a signifi-
cant goal.[57] The use of chloramine-T in the generation of
isoxazole-linked peptidomimetics,[48b] in antibody-catalysed
cycloaddition reactions and in the preparation of 125I-lab-
elled oligonucleotides[58] suggests, with judicious choice of
reactant concentrations, harmony with biological systems.
Chloramine-T mediates nitrile oxide formation from al-
doxime precursors; it is also capable of transforming
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Figure 3. Nucleoside conjugates prepared by NOAC; nitrile oxides
generated from oximes by PhI[OC(O)CF3]2-induced oxidation.[56]
hydrazones into nitrile imines.[59] The choice of this reagent
for nitrile oxide generation facilitates a move away from the
biphasic (water/CH2Cl2) systems desirable for the NCS/
NBS NEt3 protocols and found to be valuable for rate en-
hancements of NaOCl-promoted intramolecular cycload-
ditions.[60] Chloramine-T is a versatile reagent that can be
used with both acid- and base-sensitive substrates. Issues
relating to base-sensitive substrates have been circumvented
by co-employment of silica gel,[53a] whereas the presence of
a mild base (e.g., NaHCO3) is sufficient to protect acid-
sensitive functionalities. One plausible mechanism for the
transformation of aldoximes into nitrile oxides through
chloramine-T induction is shown in Scheme 3.[59] For appli-
cation of the chloramine-T protocol a number of caveats
apply; one should heed Padmavathi’s observations that side
reactions of the initially generated nitrile oxide with excess
chloramine-T (4 equiv.) can give undesired products and de-
tract from the yield of the desired dipole,[59] as well as Rai’s
observations that some reaction partners (e.g., vinyl sulf-
ones) might not be inert to the oxidising power of chlora-
mine-T. A pragmatic solution to the latter problem involves
exposure of the oxime to the chloramine-T prior to addition
of the dipolarophile.[61]
Scheme 3. Mechanism proposed by Padmavathi and co-workers for
the formation of nitrile oxides from oximes through chloramine-T
induction.[59]
Nitrile Oxide/Alkyne Cycloadditions
Nucleoside analogues can be formed by nitrile oxide
click chemistry induced by chloramine-T either conven-
tionally in solution or also under solid-phase conditions.[62]
Many antiviral nucleoside analogues require 5-hydroxy
groups for kinase phosphorylation, but some 5-tritylated
derivatives demonstrate inhibition of thymidine phospho-
rylase and angiogenesis,[63] so access both to 5-protected
and to 5-unprotected thymidine derivatives is important.
Thymidine substrates bearing free hydroxy groups at
their 5-positions, as well as those protected as trityl or di-
methoxytrityl ethers, are compatible with the NOAC proto-
col with chloramine-T induction. Propargyl moieties, easily
introduced at the 3-position of the deoxyribose moiety, can
function as the alkyne handles and the active dipoles can
be generated from the parent oximes by treatment with
chloramine-T in aqueous ethanolic NaHCO3. The one-pot,
catalyst-free protocol avoids issues with reactive oxygen
species and there is no requirement to exclude air from the
reaction. Cycloadditions to the protected and unprotected
nucleosides 1 and 2 are complete after stirring for 1 h at
room temperature (Scheme 4). The reactions allow selective
formation of 3,5-disubstituted isoxazoles 3/4, as is evident
in the 1H NMR spectra of the products; the 4-H protons
of the isoxazole rings are each characterised by a singlet
resonance at about 6.5 ppm. The isoxazole ring protons of
the alternative 3,4-disubstituted regioisomers ought to reso-
nate approximately 1 ppm further downfield.[50]
Scheme 4. Thymidine conjugates prepared through cycloadditions
between terminal alkynes and nitrile oxides generated by the chlo-
ramine-T protocol: i) RCHNOH, chloramine-T, NaHCO3, EtOH/
H2O, 1 h, r.t.[62b]
Nucleoside derivatives conjugated with two identical
groups can be accessed by “click-click” NOAC. C3,O,N3-
Bispropargyl thymidines 5 or 6 (Scheme 5), for example,
with the 5-hydroxy group either tritylated or free, can func-
tion as bis-dipolarophiles. These substrates, when exposed
to suitable oximes and chloramine-T, can undergo two inde-
pendent nitrile oxide/alkyne click cycloaddition reactions.
As was evident from their 1H NMR spectra, the double
cycloaddition products 7/8 form without any compromise
in regioselectivity. Concomitant with cycloaddition is the
disappearance of the alkyne proton resonance and down-
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field shifts (ca. 0.5 ppm) in the positions of both the NCH2
and the OCH2 methylene protons. No other regioisomer
was found amongst the crude products.[62b] The regioselec-
tivity of the isoxazole-forming NOAC reaction is thus on a
par with that of the copper-promoted triazole click ligation
procedures.
Scheme 5. Formation of doubly modified nucleoside derivatives by
click-click NOAC chemistry in solution: i) RCHNOH, chloramine-
T, NaHCO3, EtOH/H2O, 1 h, r.t.[62b]
Conformation, configuration and conjugation are impor-
tant features of modified oligonucleotides, and conse-
quently site-specific reactivity is an important synthetic
goal. There is particular interest in substituents at the 2-
position, which lock the ribose sugar in the C3-endo con-
formation preferred by the RNAi intracellular ma-
chinery.[64] Commercially available 500-Å CPG-succinyl nu-
cleosides 9 [controlled pore glass, Eq. (2)] bearing click-ad-
dressable 2-O-propargyl tags can serve as reactive partners
in nitrile oxide/alkyne click chemistry.[65] The protocol in-
volves mixing the desired oxime, as nitrile oxide precursor,
and chloramine-T in aqueous EtOH in advance of exposure
to the resin-supported nucleoside alkynes in an Eppendorf
tube followed by agitation at room temperature. Formation
of the active dipole by the prior mixing of the oxime and
the oxidising agent is rapid; effectively it offers convenient
access to “pre-formed” nitrile oxides. All four natural bases,
with their standard protecting groups, can function as click
partners under these conditions, and after reaction workup
the newly generated isoxazoles are immune to the condi-
tions required for base deprotection. Conjugation can be
achieved both with aliphatic and with aryl nitrile oxides,
but the rates of cycloaddition mirror the steric bulk of the
dipoles. After time intervals ranging between 15 min and
16 h near quantitative conjugation can be achieved. HPLC
analysis is a suitable tool to ascertain click efficiency and
selectivity; typically the ligated adducts elute ca. 6 min later
than the parent propargylated nucleosides.
In addition, derivitisation of CPG-succinyl nucleosides 9
by the chloramine-T-induced NOAC protocol can be di-
rectly performed in a DNA synthesis column, by conduc-
tion of the reaction with an agitated suspension of resin-
supported reactant in an Eppendorf tube[65]; see Eq. (2).
This augurs well for future commercial automation. Indeed,
Carell and co-workers, starting from hydroxamoyl chloride
precursors, have elegantly achieved nitrile oxide/styrene




To be valuable for synthesis of nucleotide conjugates the
NOAC protocol must demonstrate compatibility with all
components of these complex molecules: that is, the phos-
phodiester as well as the base and sugar components. Suc-
cessful click conjugation to the synthetic nucleotide 14
(Scheme 6) provides confirmation that the phosphodiester
moiety can tolerate the NOAC protocol mediated by chlo-
ramine-T.[62b] The alkyne-bearing nucleotide was prepared
after coupling of the 5-protected thymidine phosphoramid-
ite 11 with the alkynyl alcohol 12 under standard condi-
tions. Removal of the Dmt protecting group gave 14, which
can, on exposure to chloramine-T in ethanolic NaHCO3,
behave as a click partner with nitrile oxides generated in
situ from the appropriate oximes. The one-pot reaction is
fast at ambient temperature and is complete in under one
hour. It compares favourably with the copper-catalysed for-
Scheme 6. Isoxazole-ligated synthetic dinucleotides prepared by
NOAC in solution: i) anh. CH3CN, BMT, Ar, 0.5 h, room temp.,
then oxidation; ii) DCA, CH2Cl2, room temp., 0.5 h;
iii) RCHNOH, chloramine-T, NaHCO3, EtOH, 1 h, r.t.[62b]
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mation of triazole-linked dithymidines, which, although
complete within 3 min under microwave activation condi-
tions (80 °C, 300 W), require 24 h to reach ca. 40% comple-
tion at room temperature.[67] The isoxazole-ligated nucleo-
tides 15 and 16 were obtained in 70–80% yields (Scheme 6).
The characteristic resonance position of the isoxazole 4-H,
in the δ = 6.6 ppm region, confirms the regioselectivity of
the reactions.
Nucleotide analogues can also be prepared by resin-sup-
ported NOAC chemistry.[62a,65] Model substrates, anchored
to the resin through their 3-hydroxy groups and carrying
terminal propargyl functionalities at their 5-positions as
the addressable tags (Scheme 7), can be derivitised by the
click conjugation protocol, as illustrated for 17. The reac-
tion involves direct addition of the oxime and chloramine-
T to a suspension of the resin-supported substrate in ethan-
olic NaHCO3 in an Eppendorf tube at room temperature.
Formation of isoxazole conjugates such as 18 is complete
in less than an hour. In comparison with analogous copper-
promoted triazole ligation strategies the NOAC protocol is
appealing in its simplicity; there is no need to exclude oxy-
gen from the reaction vessel and the number and variety of
reagents requiring optimisation are minimal.
Scheme 7. Isoxazole-ligated synthetic dinucleotides prepared by
NOAC with resin-supported alkyne nucleotides: i) PhCHNOH,
chloramine-T, NaHCO3, EtOH, 1 h, room temp.; ii) cleavage and
deprotection.[62b]
Positional control of oligonucleotide modification can be
important; indeed, the delivery capabilities of siRNA conju-
gates are known to vary with the site of attachment.[68] A
valuable feature of the NOAC protocol is its ability to pro-
vide designer conjugates; ligation can, if required, be
achieved at either the 3- or the 5-termini – or both – of
an oligonucleotide substrate. Mono- and bis-ribonucleotide
conjugates 22–24 (Figure 4) can be prepared by resin-sup-
ported mono-click, or bis-click-click, cycloadditions. The
reactions can be carried out with nucleotides bearing ter-
minal propargyl appendages either at the 3-end of the mo-
lecule (19) or at the 5-end (20), as well as at both the 3-
and the 5-termini (21). For each of the transformations,
the dipole was pre-formed in aqueous ethanol by treatment
of the desired oxime with chloramine-T. This solution was
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Figure 4. 2-OMe oligoribonucleotide conjugates prepared by NOAC chemistry.[65]
subsequently transferred to an Eppendorf tube containing
a suspension of the resin-supported oligonucleotide. In the
formation of 22 it has been shown that 2-O-propargyl moi-
eties at the 3-terminus of a dinucleotide can be addressed
as click partners. Bulky dipoles react more slowly than
those with lesser steric requirements (e.g., formation of the
naphthyl-substituted cycloadduct requires 4 h to reach
completion at room temperature; in direct comparison, for-
mation of phenyl-substituted isoxazole conjugates requires
only a 15 min reaction time). The formation of the tetramer
23 shows that the NOAC protocol can be used to conjugate
oligonucleotides bearing terminal alkynes at their 5-posi-
tions. High levels of cycloaddition efficiency are retained in
the click-click product 24, confirming the robust nature of
the protocol and suggesting future applications of NOAC
in high-density functionalisation.
5.3. Oligonucleotide Conjugates
The need to provide chemically modified oligonucleo-
tides for a range of biological and therapeutic applications
has focused much synthetic effort in this direction.[69] Pion-
eering research by the groups of Sella,[70] Carell,[19a,66,71]
Brown,[72] Morvan[73] and others[74] offers an insight into
the value of the CuAAC reaction for triazole-mediated
DNA ligation, whereas we and others have developed
NOAC chemistry as an effective, catalyst-free alternative.
The acceptance of dipolar cycloaddition chemistry as a
platform for oligonucleotide conjugation is reflected in the
number of commercial sources offering diverse click rea-
gents. In general, the marketed products involve azide di-
poles, although a kit and a method for modifying in vitro
synthesized RNA through click reactions including nitrile
oxides and nitrones, as well as azides, is claimed. The kit
consists of phosphoramidites or nucleoside triphosphates
bearing one component of the click cycloaddition reaction
together with a biomolecular probe with the complemen-
tary functionality. It claims the capability for modification
of RNA either during or after the chemical synthesis, with
potential advantages including low cost, easy operation,
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mild conditions, good modification effect and no influence
on the bioactivity of RNA.[75]
5.3.1. On-Resin Conjugation
Nitrile oxide/alkyne cycloaddition chemistry promoted
by chloramine-T can provide isoxazole-linked oligonucleo-
tide conjugates. Propargyl-terminated, CPG-supported
DNA substrates 25 (Scheme 8) can be ligated after reaction
with nitrile oxides generated in situ. The reactions take
place in aqueous ethanolic NaHCO3 at rates dependent on
the steric demands of the dipole partners (0.5 to 18 h). In
all cases, product integrity is readily established by HPLC
analysis and MALDI-TOF-MS data. Potential concerns re-
lating to side reactions between the nitrile oxides and the
nucleobases could be ruled out after a control experiment
that returned CPG-supported decathymidylate 25a un-
changed under the conditions of the NOAC reaction.[62a]
Scheme 8. Isoxazole conjugates prepared by NOAC with resin-sup-
ported alkyne-oligonucleotides: i) RCHNOH, chloramine-T,
NaHCO3, EtOH, room temp.; ii) cleavage and deprotection. R =
phenyl, 1-naphthyl, 9-anthracenyl. a) DNA = T10. b) DNA = 5
TCG CAC ACA CGC 3.[62a]
5.3.2. Click Prior to Conjugation
Prospective problems of operational efficiency or func-
tional group tolerance in the preparation of isoxazole-li-
gated oligonucleotides can be avoided by coupling of phos-
phoramidite building blocks already bearing the moiety to
be conjugated. Although click-generated designer triazole
phosphoramidites have been prepared by CuAAC chemis-
try,[76] isoxazole analogues are virtually unknown.[77] The
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isoxazole building blocks 28 (Scheme 9), with pendant hy-
droxy functionalities, can be prepared by the NOAC proto-
col with induction by chloramine-T; the reactions involve
in situ dipole generation from the oximes 27 and trapping
with phenyl propargyl ether. The click-generated products
can be converted into the phosphoramidites 29, which can
in turn be employed as monomers for either manual or
automated solid-phase coupling to the 5-terminus of a
growing oligonucleotide (Scheme 9).[78] Yields of conjugates
30, derived from isoxazoles generated off-resin, compare
favourably with those obtained for similar conjugates con-
Scheme 9. NOAC induced by chloramine-T, isoxazole phos-
phoramidite formation and preparation of DNA conjugates:
i) chloramine-T, EtOH/H2O, HCCCH2OPh, room temp., 18 h;
ii) BMT, (iPr2N)2POCH2CH2CN, (iPr2)NH, room temp., MeCN,
30 min; iii) BMT, (iPr2)NH, room temp., MeCN, 30 min; iv) oxi-
dation, cleavage and deprotection.[78]
Figure 5. Retrosynthetic routes to oligonucleotide conjugates uti-
lising a) off-resin,[78] and b) on-resin[62a] NOAC chemistry.
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structed by on-resin NOAC chemistry with alkyne-modified
DNA substrates (Figure 5, path b).[62a]
6. Strain-Promoted Cycloadditions of Nitrile
Oxides (Nitrones) and Alkynes
The first examples of strain-promoted nitrile oxide cyclo-
addition involved norbornene-modified DNA substrates.[79]
The strained alkene, introduced into a growing DNA strand
by way of a modified thymidine phosphoramidite, is suited
to cycloaddition with a variety of nitrile oxides generated
in situ either from hydroxamoyl chlorides or directly by
treatment of the parent oxime with NCS. The success of the
reaction forming the 2-isoxazoline – see Eq. (3) – is based
on the release of about 6 kcalmol–1 of angular strain energy
of the norbornene ring system. An attractive feature of this
reaction is its applicability to automation on a DNA syn-
thesiser; however, although being exo-selective it proceeds
without regioselectivity.[79]
(3)
A number of groups have capitalised on the potential,
pioneered by Bertozzi and co-workers,[35a] of cyclooctynes
as highly reactive dipolarophiles. With these substrates,
which release almost 18 kcalmol–1 of strain energy during
cycloaddition, the requirement for a (cytotoxic) catalyst to
promote azide/alkyne cycloaddition is redundant and the
azide/alkyne reaction earns the revered status of biocompat-
ibility. Although numerous applications with living systems
have been reported,[36d,40,80] this chemistry has more re-
cently been exploited in the nucleic acids space. Examples
include room-temperature labelling of DIBO-modified (di-
benzocyclooctyne-modified) oligonucleotides either at the
5- or the 3-termini with fluorescent or oligosaccharide
groups; the same handle is exploited in formation of 5-
labelled DNA- or RNA-peptidic or sugar conjugates[37c,81]
and in templated DNA ligation.[72b] In their reactions with
Figure 6. DNA ligation product formed by SPAAC chemistry.[72b]
For clarity only one regiosiomer of the triazole conjugates is
shown.
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azides, dibenzocyclooctynes are found to be more reactive
cycloaddition partners than monocyclic octynes; formation
of the templated DNA ligation product shown in Figure 6
is thus complete within the first minute of exposure. Signifi-
cantly, it is observed that Cu(1) strongly inhibits the
SPAAC, probably as a result of complexation to the cyclic
alkyne.[72b]
6.1. Click Conjugation to Monocyclic Alkynes
Complex syntheses and unfavourable kinetics with bulky
dipoles can limit the preference for cyclooctynes of en-
hanced reactivity (e.g., diaryl or fluorinated variants) as az-
ide click partners. Recently it has been remarked that the
steric requirement of the conjugating moiety limits the ex-
tent of peptide polymer conjugation.[82] Simple unactivated
monocyclic octynes with reduced lipophilicity and limited
steric bulk could therefore be valuable. The ensuing adducts
ought to have superior aqueous solubilities and reduced
tendencies to interact with hydrophobic biomolecules, char-
acteristics valued in drug delivery, biomedicine and im-
aging. For these reasons, our group were interested in de-
veloping protocols for strain-promoted conjugation to oli-
gonucleotides bearing monocyclic octyne moieties. The
range of commercially available azide dipoles and the wide-
spread adoption of click imaging by non-chemists inspired
us to explore azides as well as nitrile oxide dipoles.
6.1.1. Click Conjugation between Azides and Monocyclic
Alkynes
Resin-supported oligonucleotide cyclooctynes such as 31
(Figure 7), constructed from the new phosphoramidite 32,
were found to be resilient to the standard conditions of so-
lid-phase oligonucleotide synthesis. Click cycloaddition to
the monocyclic strained alkyne can be achieved at room
temperature with use of 20 equivalents of azide, at an effec-
tive concentration of ca. 140 mm,.[83] The reaction medium
is dictated by dipole solubility and the time required for
formation of the triazole conjugates 33 (20 min/16 h) is di-
rectly influenced by the size of the dipole. The range of
Figure 8. Selected azide click partners for SPAAC with DNA-cyclooctyne 31.[83]
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azide substrates includes benzyl, cinnamyl, glucose, couma-
rin, biotin and cholesterol azides (Figure 8). Potential drug
delivery applications[74a] make conjugation to cholesteryl
dipoles significant; earlier syntheses of cholesterol conju-
gates by CuAAC either at the monomer level, prior to oli-
gonucleotide synthesis, or directly to a resin-supported oli-
gonucleotide-alkyne required microwave assistance (60 °C,
45 min).[74a,84]
Figure 7. Phosphoramidites, DNA-cyclooctynes and triazole-
ligated oligonucleotides prepared by SPAAC.[83]
Despite the obvious attractions of solid-phase syntheses
(SPS), the precondition that the final products be inert to
the cleavage/deprotection protocols can be prohibitive. To
allow for such eventualities and to claim full versatility for
SPAAC with monocyclic cyclooctynes a solution-phase syn-
thesis of the triazole-ligated fluorescein conjugate 34 (Fig-
ure 9) has been demonstrated.[83] The observed propensity
of the fluorescein core to lactonise under the basic condi-
tions required for cleavage of the conjugate from the resin
precludes its synthesis by the resin-supported approach. An
aqueous solution of DNA-cyclooctyne, obtained from 31
after deprotection and cleavage from the resin, can thus be
conjugated after exposure to an aqueous DMF solution of
fluorescein azide. The reaction requires agitation at room
temperature overnight. Optimum rates of conversion to the
conjugate (≈80%) require a doubling of the number of azide
equivalents (40 equiv.) relative to that required for analo-
gous solid-phase reactions.
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Figure 9. Triazole-ligated DNA conjugate prepared in solution
phase by SPAAC.[83]
6.1.2. Click Conjugation between Nitrile Oxides and
Monocyclic Alkynes
Recent studies on the relative reactivities of nitrile oxides,
nitrones and diazocarbonyl derivatives as alternatives to az-
ide dipoles in reaction with cyclooctynes suggest inferior
kinetics (with respect to azides) for diazocarbonyl moieties
and superior reactivities for strain-promoted alkyne/nitrile
oxide cycloaddition (SPANOC).[43b,56] Theoretical studies
concluded that bond angle and strain release, together with
the attainment of aromatic status in the isoxazole product,
are the driving forces for the reaction.[85] The relative reac-
tivities of nitrones are closely related to their structures,
with cyclic nitrones being the most effective dipoles.[43b,86]
Interestingly, in spite of their modest reactivities, peptides
bearing nitrone moieties can still be trapped with dibenzo-
cyclooctyne (DIBO) derivatives at rates sufficiently high to
permit selective tagging of proteins and complex carbo-
hydrates.[87] The rate constant for [3+2] addition of bicy-
clo[6.1.0]nonyne (BCN) 35 (Figure 10) to benzonitrile oxide
(1.8 m–1 s–1) was found to be greater by a factor of 10 than
that observed for the corresponding reaction with benzyl
azide.[56] Similar results were observed with DIBO; benzoni-
trile oxide (generated in situ from the hydroxamoyl chlor-
ide) reacted about 60 times more rapidly than benzyl azide
(Scheme 10). Oximation, oxidation and cycloaddition can
be streamlined as a one-pot reaction, which is especially
attractive from an experimental perspective. The potential
of the telescopic process, which is based on on keeping the
dibenzocycloalkyne separate from the hydroxylamine, is evi-
dent from its ability to yield biotin-labelled carbohydrates
and sialic-acid-labelled glycoproteins (Scheme 11).[43b]
Isoxazole nucleoside conjugate 36 (Figure 10) can be
formed by PIFA-induced nitrile oxide/alkyne cycloaddition
to BCN 35. The reaction, which occurs within minutes in
aqueous methanol under ambient conditions, suggests that
this approach can be valuable for applications requiring de-
rivatisation of unprotected nucleosides.[56] It is well known
that nitrile oxides have a tendency to dimerise in the ab-
sence of a suitable reaction partner, but a further word of
caution with regard to the use of hypervalent iodine rea-
gents is prompted by the observation that aliphatic or aro-
matic aldoximes, in the presence of (diacetoxyiodo)benzene
(DIB) or [hydroxy(tosyloxy)iodo]benzene (HTIB) can yield,
rather than the expected nitrile oxides (or their dimerization
products), the corresponding N-acetoxy and N-hy-
droxyamides.[88]
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Figure 10. Bicyclo[6.1.0]nonyne (BCN) 35 and nucleoside analogue
36, formed by strain-promoted nitrile oxide/alkyne cycloaddition
(SPNOAC).[56]
Scheme 10. Cycloaddition between dibenzocyclooctynol (DIBO)
and benzyl azide or benzonitrile oxide dipoles.[43b]
Scheme 11. Telescopic one-pot SPNOAC; BAIB = bis(acetoxy)-
iodobenzene.[43b]
The sluggish reactivities of monocyclic cyclooctynes af-
ford an opportunity to showcase the attributes of nitrile
oxides as dipoles. Strain-promoted cyclooctyne/nitrile oxide
click cycloadditions between the resin-supported DNA-cy-
clooctyne 31 (Figure 7) and a range of nitrile oxides gener-
ated in situ can be achieved in near-quantitative yields
within 10 min at room temperature. Reaction conditions are
straightforward: a solution of the nitrile oxide dipole, gener-
ated by pre-mixing the parent oximes and chloramine-T (in
a 1:1 ratio), is added to a suspension of the resin-supported
oligonucleotide in an Eppendorf tube. Solvent choice –
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EtOH, DMF, water or mixtures of the same – is dictated
by dipole solubility issues. As expected, the selectivity ob-
served in addition to the terminal alkyne is sacrificed with
the cyclic substrate. The regioisomeric isoxazole-DNA con-
jugates 37/38 (Figure 11) represent the first examples of
resin-supported DNA ligation by exploitation of a monocy-
clic alkyne as click partner. On comparison with similar
acyclic substrates (e.g., 25) it is clear from the reduction in
activation barrier associated with the cyclic alkyne that the
click reaction can be executed with a much reduced concen-
tration of dipole.[89] The reaction is tolerant of nitrile oxides
bearing bulky aryl groups, including pyrenyl groups, and is
also compatible with the hydroxy functional group, which
could represent a useful handle for further modification of
DNA. Finally, formation of the coumarin conjugates 39
(only one regioisomer shown) suggests that this method can
be used to provide fluorescently labelled conjugates.
Figure 11. Isoxazole-ligated DNA conjugates prepared by
SPANOC. R = phenyl, 1-naphthyl, 2-fluorophenyl, 1-pyrenyl, 2-(2-
hydroxyethoxy)phenyl.[89] For purposes of clarity, only one regiosi-
omeric isoxazole will be drawn from this point forward.
6.2. Click-Click and Click-Clunk Cycloadditions – Multiply
Functionalised Substrates
Complex molecular architectures have been assembled by
multiple click reactions (click/click) on a single substrate
(e.g., cross-linking), by stepwise or bisclick reactions or
high-density functionalisation of DNA molecules.[19a,70b,90]
More complex architectures have been achieved by mod-
ulation of a range of click chemistries (click/clunk).[10] Suc-
cessive chemoselective ligations, either stepwise or one-pot,
avoid tedious purification procedures and generally furnish
high yields of products. For these reasons substrates bearing
combinations of orthogonal “clickable” groups have been
designed; examples of complementary reactivity include ox-
ime bond formation, copper(I)-mediated alkyne/azide cy-
cloaddition and thioether bond formation, CuAAC/radical
coupling reactions SPAAC/thiol ene photochemistry and
epoxy-amine/thiol-ene coupling.[91] Threefold orthogonality
has been demonstrated with SPAAC, Diels–Alder and thiol
ene chemistries in designer decorated nanoparticles.[92] Iter-
ative click reactions furnishing doubly and triply triazole-
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decorated structures have been formed by copper-free and/
or copper-mediated azide/alkyne cycloadditions;[25] sub-
strates include representatives bearing one free and a variety
of orthogonally protected alkyne residues,[71,93] one azide
and one alkyne functionality[94] and a terminal and a cyclic
alkyne moiety, as well as those carrying various combina-
tions of free alkynes, protected alkynes and cyclic al-
kynes.[95]
Orthogonal, azide/alkyne and nitrile oxide/alkene click
cycloaddition chemistries can be applied to high-density
DNA functionalisation. DNA strands (ca. 300 base pairs)
richly decorated with styrene and propargyl functionalities
can undergo rapid CuAAC reactions upon addition of
azido sugars, together with a Cu(1) catalyst, to form inter-
mediate triazole-ligated sugar-DNA conjugates. After puri-
fication (by ethanol precipitation), the styrene units, which
are inert to azides, can then by trapped by the more reactive
nitrile oxide dipole (Scheme 12).[66]
Scheme 12. Click-clunk postsynthetic DNA functionalisation by
copper-promoted and copper-free cycloadditions.[66]
7. Applications in Supramolecular and Polymer
Chemistry
In polymer chemistry, click reactions are valued both for
polymer growth and for modification of the polymer after
the polymerisation process.[2] Traditional approaches to de-
signer polymers have involved controlled incorporation of
functional moieties.[96] Modification of the polymeric frame
has obvious attractions, however, and the ability to control
architecture and degree of functionalisation by click-type
chemistry is very attractive.[2,11a] The limitations of the cop-
per-promoted reaction, and the masked synthetic potential
of the isoxazole ring, prompted us and others to explore
the potential of nitrile oxides as click cycloaddition partners
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for formation of supramolecular constructs or polymers of
predefined structure.
7.1. NOAC in the Construction of Supramolecular and
Polymer Architectures
An early reference to nitrile oxides as clickable function-
alities appears in patent literature describing multivalent
dendrimers as pharmaceutical or diagnostic agents, en-
compassing peptides, oligopeptides, proteins and carbo-
hydrates.[97] Rotaxanes can be formed by click end-capping
reactions between nitrile oxides and alkyne-bearing pseudo-
rotaxane substrates (Scheme 13).[98] For these applications
superior results are found with preformed stable dipoles;
the click capping reactions are distinctly less successful
when in situ dipole generation is attempted with hy-
droxamoyl chlorides and NEt3, AgOTf or MS (4 Å). Isox-
azole-containing [2]rotaxanes (Scheme 13) can be obtained
in good yields after reactions either at room temperature
(ca. 1 d) or at reflux in CH2Cl2 (ca. 2 h) or 1,2-dichloroe-
thane (ca. 20 min). At higher temperatures there is a slight
sacrifice in yield attributed to entropy-driven dissociation
of the pseudorotaxane.
Scheme 13. Click end-capped [2]rotaxanes prepared by NOAC.[98]
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Click polymerisation between homo-ditopic nitrile ox-
ides and bifunctional terminal olefinic and acetylenic
monomers is a simple, yet powerful tool suited to applica-
tions in materials chemistry.[99] Taketa and co-workers show
in their work (Scheme 14) that molecular sieves (4 Å) can
function both as base and as dehydrating agent for in situ
generation of bisnitrile oxides from hydroxamoyl dichloride
precursors. Polycycloadditions can be executed with diynes;
more recently it has been shown that bisnitriles are also
suitable polymerisation partners.[99] Polymerisation is
achieved at 80 °C in DMF with a 1:1 ratio of reactants. The
high degree of homogeneity of the polyisoxazole products
is attributed to the regiochemical preference for formation
of the 3,5-disubstituted isoxazole: polydispersity indexes are
typically between 1.3 and 2.0. The isoxazole ring can be
envisaged as masking a range of functionalities including
aldol, diketone, amino alcohol etc. and Takata and co-
workers have begun to unveil this potential, demonstrating
controlled or complete reduction to poly(β-aminoenones)
or poly(β-amino alcohols).[99]
Scheme 14. Polymer formation by NOAC between bis(nitrile ox-
ides) and diynes and transformation of the polyisoxazole by con-
trolled and full reduction.[99]
In a further elaboration of macromolecular architecture
it has been shown that trifunctional aromatic nitrile oxides
can behave as crosslinking agents. Dipole formation from
the trioximes is facilitated by treatment of the parent ox-
imes either with N-chlorosuccinimide and Et3N or with
bromine and NaOH.[100]
7.2. Post-Synthetic Click Modification of Polymers by
NOAC
Chain-end polymer functionalization can be achieved
through NOAC chemistry. Alkyne-functionalised biocom-
patible telechelic copolymers 40 and 41 (Figure 12) suc-
cumb to the chloramine-T-induced NOAC protocol. The
click products, arising from reaction with aryl nitrile oxides,
formed in situ from the parent oximes, are illustrated in
Figure 12. The reactions are easily executed at room tem-
perature in aqueous ethanol in the presence of NaHCO3.
Generally, cycloaddition is complete in 16 h, although if
progress is poor – with sterically encumbered dipoles, for
example – repetition of the dose of oxime and chloramine-
T after 12 h enhances the conversion. Purification of the
conjugated polymeric products from excess reagents can be
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Figure 12. Chain-end polymer modification by post-synthetic NOAC modification at the α-terminus; R = phenyl, 2-fluorophenyl, 2-
nitrophenyl, 1-naphthyl, 9-anthracenyl.[101a]
easily achieved by dialysis. The near quantitative reaction
was confirmed as highly regioselective by 1H NMR spectro-
scopic analysis. Compatibility of the NOAC protocol with
the inherent polymer structure is confirmed by size ex-
clusion chromatography (SEC), turbidity and cloud point
measurements, which show the click functionalized poly-
mers 42 and 43 to have the same molecular weights and
molecular weight distributions prior and subsequent to
click modification.[101a]
Copper-free NOAC and copper-promoted CuAAC cy-
cloadditions can be combined in a new embodiment of
click-clunk cycloaddition chemistry for post-synthetic
modification of polymer substrates at their α- and
ω-termini.[101b] The potential of this chemistry is demon-
strated with model, heterotelechelic, polystyrene polymers
44 (Scheme 15), bearing α-alkyne and ω-azido end-groups.
The poor kinetics of the azide/alkyne cycloaddition in the
absence of a catalyst permit orthogonal modification of un-
Scheme 15. Click-clunk end-capping of α-alkyne-ω-azidopolystyrene polymers by complementary NOAC and CuAAC chemistries; R =
phenyl, 1-naphthyl; R = CH2OH, C(O)CH3.[101b]
Eur. J. Org. Chem. 2012, 3043–3058 © 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim www.eurjoc.org 3055
symmetrical substrates bearing these functionalities. Initial
exposure of 44 to the nitrile oxide (generated in situ) ef-
ficiently traps the alkyne moiety in a NOAC reaction. The
active dipole for the NOAC can be formed in the presence
of the polymer by NEt3-induced dehydrochlorination of the
precursor hydroxyamoyl chloride. During the formation of
45 the azide dipole remains inert. After purification, by sim-
ple precipitation from methanol, the cycloaddition poten-
tial of the azide moiety of the polymeric intermediate 45
can be unlocked. Addition of an external alkyne together
with a copper catalyst yields the doubly modified polymers
46. Both the isoxazole- and the triazole-forming reactions
proceed with excellent regioselectivities and chemical yields.
The incorporation of a fluorescein moiety in 47 suggests
possible application in polymer labelling for biomedical
studies. Molecular weight and molecular weight distribu-
tion measurements of the click-clunk polymers 46 mirror
those of the precursors, suggesting that both the NOAC
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Scheme 16. Control of click, clunk or click-clunk functionalization by choice of reaction conditions: i) dibenzocyclooctyne, MeOH,
room temp.; ii) BAIB, MeOH, room temp.; iii) dibenzocyclooctyne (R substuituent), MeOH room temp., then dibenzocyclooctyne (R
substuituent), BIAB.[43b]
and the CuAAC chemistries are suited to post-synthetic
polymer modification.
In another manifestation of the orthogonality of azides
and nitrile oxides, Sanders and co-workers have shown that,
with judicious choice of reaction conditions, controlled
modification of bifunctional azidooxime substrates 48 is
possible (Scheme 16). If the reactants are simply mixed in
MeOH at room temperature a triazole-forming SPAAC re-
sults in formation of 49. However, in the presence of BAIB,
the latent oxime rapidly provides a nitrile oxide with which
the azide is insufficiently reactive to compete for the di-
polarophile and an isoxazole forms through a SPANOC re-
action, to afford 50. Sequential azide/nitrile oxide cycload-
ditions allow the creation of multifunctional products 51 in
one-pot fashion simply by controlling the order of addition
of the reagents.[43b]
Conclusions
This review has covered some of the shortcomings of the
azide/alkyne click reaction and overviewed the most com-
monly applied solutions to the problems associated with
copper toxicity and residual catalyst ions. It proposes that
nitrile oxide/alkyne cycloaddition (NOAC) reactions and
strain-promoted nitrile oxide/alkyne cycloadditions
(SPNOACs) can be likened to “molecular adhesives” cap-
able of weaving components together in a catalyst-free envi-
ronment, without the need for any specialised reaction set-
up. Although the propensity of nitrile oxides to get involved
in side reactions, including dimerisation and nucleophilic
attack, might have discouraged some researchers from
studying their potential as a conjugation methodology, the
kinetics of the nitrile oxide alkyne/cycloaddition can confer
favoured status on this dipole and justify application of the
term “superglue” to the NOAC reaction. This article fo-
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cuses primarily on applications in the spheres of nucleic
acid and polymer chemistry, but it cannot be doubted that
applications of nitrile oxide click cycloadditions will con-
tinue to emerge across the broad field of conjugation chem-
istry. It can be concluded that NOAC holds great promise
as a premier player in the click toolbox and will certainly
contribute to future creative advances in chemical biology
as well as in materials science.
Acknowledgments
Financial support from the Science Foundation of Ireland (Pro-
gramme code 05/PICA/B838) is acknowledged.
[1] H. C. Kolb, M. G. Finn, K. B. Sharpless, Angew. Chem. 2001,
113, 2056; Angew. Chem. Int. Ed. 2001, 40, 2004–2021.
[2] J. Lahann (Ed.), Click Chemistry for Biotechnology and Mate-
rial Science, Wiley, U. K., 2009.
[3] a) V. V. Fokin, P. Wu, in: Aziridines and Epoxides in Organic
Synthesis (Ed.: A. K. Yudin), Wiley-VCH, New York, 2006,
pp. 443–477; b) Y. Singh, N. Spinelli, E. Defrancq, Curr. Org.
Chem. 2008, 12, 263–290; T. S. Zatsepin, D. A. Stetsenko, M. J.
Gait, T. S. Oretskaya, Bioconjugate Chem. 2005, 16, 471–489.
[4] C. E. Hoyle, C. N. Bowman, Angew. Chem. 2010, 122, 1584;
Angew. Chem. Int. Ed. 2010, 49, 1540–1573.
[5] G. Franc, A. K. Kakkar, Chem. Eur. J. 2009, 15, 5630–5639.
[6] C. W. Tornoe, C. Christensen, M. Meldal, J. Org. Chem. 2002,
67, 3057–3064.
[7] A. Michael, F. Luehn, H. H. Higbee, Am. Chem. J. 1898, 20,
377–395.
[8] R. Huisgen, Angew. Chem. 1963, 75, 604–637.
[9] a) H.-F. Chow, K.-N. Lau, Z. Ke, Y. Liang, C.-M. Lo, Chem.
Commun. 2010, 46, 3437–3453; b) Y. Hua, A. H. Flood, Chem.
Soc. Rev. 2010, 39, 1262–1271.
[10] R. K. Iha, K. L. Wooley, A. M. Nystrom, D. J. Burke, M. J.
Kade, C. J. Hawker, Chem. Rev. 2009, 109, 5620–5686.
[11] a) M. Meldal,Macromol. Rapid Commun. 2008, 29, 1016–1051;
b) P. L. Golas, K. Matyjaszewski, Chem. Soc. Rev. 2010, 39,
Nitrile Oxide/Alkyne Cycloadditions
1338–1354; c) J.-F. Lutz, Angew. Chem. 2007, 119, 1036; Angew.
Chem. Int. Ed. 2007, 46, 1018–1025.
[12] a) S. K. Mamidyala, M. G. Finn, Chem. Soc. Rev. 2010, 39,
1252–1261; b) V. Aragao-Leoneti, V. L. Campo, A. S. Gomes,
R. A. Field, I. Carvalho, Tetrahedron 2010, 66, 9475–9492.
[13] J. Cao, X. Huang, J. Comb. Chem. 2008, 10, 526–533.
[14] V. V. Fokin, ACS Chem. Biol. 2007, 2, 775–778.
[15] R. A. Decreau, J. P. Collman, A. Hosseini, Chem. Soc. Rev.
2010, 39, 1291–1301.
[16] E. Lallana, R. Riguera, E. Fernandez-Megia, Angew. Chem.
Int. Ed. 2011, 50, 8794–8804.
[17] J. Xu, T. M. Filion, F. Prifti, J. Song, Chem. Asian J. 2011, 6,
2730–2737.
[18] L. M. Gaetke, C. K. Chow, Toxicology 2003, 189, 147–163.
[19] a) J. Gierlich, G. A. Burley, P. M. E. Gramlich, D. M. Ham-
mond, T. Carell, Org. Lett. 2006, 8, 3639–3642; b) J. G. Brewer,
Chem. Res. Toxicol. 2010, 23, 319–326.
[20] a) M. E. Martin, S. G. Parameswarappa, M. S. O’Dorisio, F. C.
Pigge, M. K. Schultz, Bioorg. Med. Chem. Lett. 2010, 20, 4805–
4807; b) S. Sawoo, P. Dutta, A. Chakraborty, R. Mukho-
padhyay, O. Bouloussa, A. Sarkar, Chem. Commun. 2008,
5957–5959.
[21] a) C. Ornelas, J. Ruiz Aranzaes, E. Cloutet, S. Alves, D. Astruc,
Angew. Chem. 2007, 119, 890; Angew. Chem. Int. Ed. 2007, 46,
872–877; b) J. Hong, Q. Luo, B. K. Shah, Biomacromolecules
2010, 11, 2960–2965.
[22] J. E. MacDonald, J. A. Kelly, J. G. C. Veinot, Langmuir 2007,
23, 9543–9545.
[23] a) Y. Zou, J. Yin, Bioorg. Med. Chem. Lett. 2008, 18, 5664–
5667 b) A. Bernardin, A. Cazet, L. Guyon, P. Delannoy, F.
Vinet, D. Bonnaffe, I. Texier, Bioconjugate Chem. 2010, 21,
583–588; c) L. A. Canalle, T. Vong, P. H. M. Adams, F. L.
van Delft, J. M. H. Raats, R. G. S. Chirivi, J. C. M. van Hest,
Biomacromolecules 2011, 12, 3692–3697.
[24] S. G. Gouin, J. Kovensky, Synlett 2009, 1409–1412.
[25] X. Deng, C. Friedmann, J. Lahann, Angew. Chem. Int. Ed.
2011, 50, 6522–6526.
[26] A. Kiviniemi, P. Virta, H. Lonnberg, Bioconjugate Chem. 2008,
19, 1726–1734.
[27] a) S. Chassaing, M. Kumarraja, A. S. S. Sido, P. Pale, J. Som-
mer, Org. Lett. 2007, 9, 883–886; b) H. Nulwala, K. Takizawa,
A. Odukale, A. Khan, R. J. Thibault, B. R. Taft, B. H. Lip-
shutz, C. J. Hawker, Macromolecules 2009, 42, 6068–6074; c)
B. S. Lee, M. Yi, S. Y. Chu, J. Y. Lee, H. R. Kwon, K. R. Lee,
D. Kang, W. S. Kim, H. B. Lim, J. Lee, H.-J. Youn, D. Y. Chi,
N. H. Hur, Chem. Commun. 2010, 46, 3935–3937.
[28] T. R. Chan, R. Hilgraf, K. B. Sharpless, V. V. Fokin, Org. Lett.
2004, 6, 2853–2855; D. Soriano del Amo, W. Wan, H. Jiang, C.
Besanceney, A. C. Yan, M. Levy, Y. Liu, F. L. Marlow, P. Wu,
J. Am. Chem. Soc. 2010, 132, 16893–16899; C. Besanceney-
Webler, H. Jiang, T. Zheng, L. Feng, S. del Amo, W. Wang,
L. M. Klivansky, F. L. Marlow, Y. Liu, P. Wu, Angew. Chem.
Int. Ed. 2011, 50, 8051–8056.
[29] a) E. Paredes, S. R. Das, ChemBioChem 2011, 12, 125–131; b)
T. Shiraishi, Y. Kitamura, Y. Ueno, Y. Kitade, Chem. Commun.
2011, 47, 2691–2693.
[30] a) L. Zhang, X. Chen, P. Xue, H. H. Y. Sun, I. D. Williams,
K. B. Sharpless, V. V. Fokin, G. Jia, J. Am. Chem. Soc. 2005,
127, 15998–15999; b) M. M. Majireck, S. M. Weinreb, J. Org.
Chem. 2006, 71, 8680–8683; c) S. Oppilliart, G. Mousseau, L.
Zhang, G. Jia, P. Thuery, B. Rousseau, J.-C. Cintrat, Tetrahe-
dron 2007, 63, 8094–8098.
[31] a) B. C. Boren, S. Narayan, L. K. Rasmussen, L. Zhang, H.
Zhao, Z. Lin, G. Jia, V. V. Fokin, J. Am. Chem. Soc. 2008, 130,
8923–8930; b) L. K. Rasmussen, B. C. Boren, V. V. Fokin, Org.
Lett. 2007, 9, 5337–5339.
[32] A. Qin, J. W. Y. Lam, B. Z. Tang, Chem. Soc. Rev. 2010, 39,
2522–2544.
[33] a) D. Imperio, T. Pirali, U. Galli, F. Pagliai, L. Cafici, P. L.
Canonico, G. Sorba, A. A. Genazzani, G. C. Tron, Bioorg.
Eur. J. Org. Chem. 2012, 3043–3058 © 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim www.eurjoc.org 3057
Med. Chem. 2007, 15, 6748–6757; b) F. Wuest, X. Tang, T.
Kniess, J. Pietzsch, M. Suresh, Bioorg. Med. Chem. 2009, 17,
1146–1151.
[34] a) U. Pradere, V. Roy, T. R. McBrayer, R. F. Schinazi, L. A.
Agrofoglio, Tetrahedron 2008, 64, 9044–9051; b) Tam, U. Ar-
nold, M. B. Soellner, R. T. Raines, J. Am. Chem. Soc. 2007,
129, 12670–12671; c) M. Chemama, M. Fonvielle, M. Arthur,
J.-M. Valery, M. Etheve-Quelquejeu, Chem. Eur. J. 2009, 15,
1929–1938; d) D. Crich, F. Yang, Angew. Chem. 2009, 121,
9058; Angew. Chem. Int. Ed. 2009, 48, 8896–8899.
[35] a) N. J. Agard, J. A. Prescher, C. R. Bertozzi, J. Am. Chem. Soc.
2004, 126, 15046–15047; b) E. Lallana, E. Fernandez-Megia,
R. Riguera, J. Am. Chem. Soc. 2009, 131, 5748–5750; c) C.
Ornelas, J. Broichhagen, M. Weck, J. Am. Chem. Soc. 2010,
132, 3923–3931.
[36] a) E. M. Sletten, C. R. Bertozzi, Org. Lett. 2008, 10, 3097–
3099; b) J. A. Codelli, J. M. Baskin, N. J. Agard, C. R. Bertozzi,
J. Am. Chem. Soc. 2008, 130, 11486–11493; c) C. A. DeForest,
B. D. Polizzotti, K. S. Anseth, Nat. Mater. 2009, 8, 659–664; d)
. P. V. Chang, J. A. Prescher, E. M. Sletten, J. M. Baskin, I. A.
Miller, N. J. Agard, A. Lo, C. R. Bertozzi, Proc. Natl. Acad.
Sci. USA 2010, 107, 1821–1826.
[37] a) A. A. Poloukhtine, N. E. Mbua, M. A. Wolfert, G.-J. Boons,
V. V. Popik, J. Am. Chem. Soc. 2009, 131, 15769–15776; b) .
S. V. Orski, A. A. Poloukhtine, S. Arumugam, L. Mao, V. V.
Popik, J. Locklin, J. Am. Chem. Soc. 2010, 132, 11024–11026;
c) . K. N. Jayaprakash, C.-G. Peng, D. Butler, J. P. Varghese,
M. A. Maier, K. G. Rajeev, M. Manoharan, Org. Lett. 2010,
12, 5410–5413.
[38] a) A. Kuzmin, A. Poloukhtine, M. A. Wolfert, V. V. Popik, Bi-
oconjugate Chem. 2010, 21, 2076–2085; b) F. Starke, M. Wal-
ther, H.-J. Pietzsch, ARKIVOC (Gainesville, FL, USA) 2010,
350–359.
[39] a) N. E. Mbua, J. Guo, M. A. Wolfert, R. Steet, G.-J. Boons,
ChemBioChem 2011, 12, 1912–1921; b) L. S. Campbell-Verd-
uyn, L. Mirfeizi, A. K. Schoonen, R. A. Dierckx, P. H. Elsinga,
B. L. Feringa, Angew. Chem. Int. Ed. 2011, 50, 11117–11120.
[40] J. C. Jewett, E. M. Sletten, C. R. Bertozzi, J. Am. Chem. Soc.
2010, 132, 3688–3690.
[41] a) T. Pasinszki, B. Hajgato, B. Havasi, N. P. C. Westwood,
Phys. Chem. Chem. Phys. 2009, 11, 5263–5272; b) N. M. Tho,
S. Malone, A. F. Hegarty, I. I. Williams, J. Org. Chem. 1991,
56, 3683–3687.
[42] H. Feuer, in: Nitrile Oxides, Nitrones, and Nitronates in Organic
Synthesis: Novel Strategies in Synthesis, Wiley, 2008.
[43] a) F. Himo, T. Lovell, R. Hilgraf, V. V. Rostovtsev, L. Noo-
dleman, K. B. Sharpless, V. V. Fokin, J. Am. Chem. Soc. 2005,
127, 210–216; b) B. C. Sanders, F. Friscourt, P. A. Ledin, N. E.
Mbua, S. Arumugam, J. Guo, T. J. Boltje, V. V. Popik, G.-J.
Boons, J. Am. Chem. Soc. 2011, 133, 949–957.
[44] E. Coutouli-Argyropoulou, P. Lianis, M. Mitakou, A. Gian-
noulis, J. Nowak, Tetrahedron 2006, 62, 1494–1501.
[45] T. M. V. D. Pinho e Melo, Curr. Org. Chem. 2005, 9, 925–958.
[46] B. L. Deng, T. L. Hartman, R. W. Buckheit, C. Pannecouque,
E. De Clercq, M. Cushman, J. Med. Chem. 2006, 49, 5316–
5323.
[47] T. Keicher, S. Lobbecke in Organic Azides: Syntheses and Appli-
cations (Eds.: S. Bräse, K. Banert), Wiley, Chichester, 2010,
pp. 3–37.
[48] a) T. V. Hansen, P. Wu, V. V. Fokin, J. Org. Chem. 2005, 70,
7761–7764; b) G. Chennakrishnareddy, B. Vasantha, N. Naren-
dra, V. V. Sureshbabu, Int. J. Pept. Res. Therap. 2011, 17, 185–
191.
[49] S. Kankala, R. Vadde, C. S. Vasam, Org. Biomol. Chem. 2011,
9, 7869–7876.
[50] S. Grecian, V. V. Fokin, Angew. Chem. 2008, 120, 8409; Angew.
Chem. Int. Ed. 2008, 47, 8285–8287.
[51] T. M. V. D. Pinho e Melo, Eur. J. Org. Chem. 2010, 3363–3376.
[52] A. Basak, K. Chandra, R. Pal, S. C. Ghosh, Synlett 2007,
1585–1588.
F. HeaneyMICROREVIEW
[53] a) T. K. M. Shing, W. F. Wong, H. M. Cheng, W. S. Kwok,
K. H. So, Org. Lett. 2007, 9, 753–756; b) V. V. Vaidya, K. S.
Wankhede, M. M. Salunkhe, G. K. Trivedi, Can. J. Chem.
2008, 86, 138–141; c. V. V. Vaidya, K. S. Wankhede, S. J. Nara,
M. M. Salunkhe, G. K. Trivedi, Synth. Commun. 2009, 39,
3856–3866.
[54] J. P. Mogensen, S. M. Roberts, A. N. Bowler, C. Thomsen,
L. J. S. Knutsen, Bioorg. Med. Chem. Lett. 1998, 8, 1767–1770;
S. J. Kim, J. Y. Lee, B. H. Kim, Bioorg. Med. Chem. Lett. 1998,
8, 1313–1316.
[55] a) Y.-S. Lee, B. Hyean Kim, Bioorg. Med. Chem. Lett. 2002, 12,
1395–1397; b) Y.-S. Lee, S. M. Park, H. M. Kim, S.-K. Park, K.
Lee, C. W. Lee, B. H. Kim, Bioorg. Med. Chem. Lett. 2009, 19,
4688–4691.
[56] A. M. Jawalekar, E. Reubsaet, F. P. J. T. Rutjes, F. L. van Delft,
Chem. Commun. 2011, 47, 3198–3200.
[57] A. Hassner, K. M. L. Rai, Synthesis 1989, 57–59.
[58] a) J. D. Toker, P. Wentworth, Y. F. Hu, K. N. Houk, K. D.
Janda, J. Am. Chem. Soc. 2000, 122, 3244–3245; b) M. W.
Reed, I. G. Panyutin, D. Hamlin, D. D. Lucas, D. S. Wilbur,
Bioconjugate Chem. 1997, 8, 238–243.
[59] V. Padmavathi, K. V. Reddy, A. Padmaja, P. Venugopalan, J.
Org. Chem. 2003, 68, 1567–1570.
[60] B. Roy, R. N. De, Monatsh. Chem. 2010, 141, 763–771.
[61] K. M. L. Rai, A. Hassner, Synth. Commun. 1997, 27, 467–472.
[62] a) I. Singh, J. S. Vyle, F. Heaney, Chem. Commun. 2009, 3276–
3278; b) V. Algay, I. Singh, F. Heaney, Org. Biomol. Chem.
2010, 8, 391–397.
[63] S. Liekens, A. Bronckaers, A.-I. Hernandez, E.-M. Priego, E.
Casanova, M.-J. Camarasa, M.-J. Perez-Perez, J. Balzarini,
Mol. Pharmacol. 2006, 70, 501–509.
[64] a) T. P. Prakash, Chem. Biodiversity 2011, 8, 1616–1641; b) M.
Manoharan, Biochim. Biophys. Acta 1999, 1489, 117–130.
[65] I. Singh, F. Heaney, Org. Biomol. Chem. 2010, 8, 451–456.
[66] K. Gutsmiedl, D. Fazio, T. Carell, Chem. Eur. J. 2010, 16,
6877–6883.
[67] R. Lucas, V. Neto, A. Hadj Bouazza, R. Zerrouki, R. Granet,
P. Krausz, Y. Champavier, Tetrahedron Lett. 2008, 49, 1004–
1007.
[68] J. H. Jeong, H. Mok, Y.-K. Oh, T. G. Park, Bioconjugate Chem.
2009, 20, 5–14.
[69] H. Lonnberg, Bioconjugate Chem. 2009, 20, 1065–1094; Y.
Singh, P. Murat, E. Defrancq, Chem. Soc. Rev. 2010, 39, 2054–
2070.
[70] a) F. Seela, V. R. Sirivolu, P. Chittepu, Bioconjugate Chem.
2008, 19, 211–224; b) S. S. Pujari, H. Xiong, F. Seela, J. Org.
Chem. 2010, 75, 8693–8696.
[71] P. M. E. Gramlich, S. Warncke, J. Gierlich, T. Carell, Angew.
Chem. 2008, 120, 3491; Angew. Chem. Int. Ed. 2008, 47, 3442–
3444.
[72] a) A. H. El-Sagheer, T. Brown, Chem. Soc. Rev. 2010, 39, 1388–
1405; b) M. Shelbourne, X. Chen, T. Brown, A. H. El-Sagheer,
Chem. Commun. 2011, 47, 6257–6259.
[73] a) G. Pourceau, A. Meyer, Y. Chevolot, E. Souteyrand, J.-J.
Vasseur, F. Morvan, Bioconjugate Chem. 2010, 21, 1520–1529;
b) G. Pourceau, A. Meyer, J.-J. Vasseur, F. Morvan, J. Org.
Chem. 2009, 74, 1218–1222.
[74] a) T. Yamada, C. G. Peng, S. Matsuda, H. Addepalli, K. N.
Jayaprakash, M. R. Alam, K. Mills, M. A. Maier, K. Charisse,
M. Sekine, M. Manoharan, K. G. Rajeev, J. Org. Chem. 2011,
76, 1198–1211; b) A. V. Ustinov, I. A. Stepanova, V. V. Dub-
nyakova, T. S. Zatsepin, E. V. Nozhevnikova, V. A. Korshun,
Russ. J. Bioorg. Chem. 2010, 36, 401–445.
[75] B. Zhang, W. Wang, D. Qu, Faming Zhuanli Shenqing, 2009,
CN 101550175, 2009, 32 pp [CAN 151:523723].
[76] P. Kocalka, N. K. Andersen, F. Jensen, P. Nielsen, ChemBio-
Chem 2007, 8, 2106–2116; M. E. Ostergaard, D. C. Guenther,
P. Kumar, B. Baral, L. Deobald, A. J. Paszczynski, P. K.
www.eurjoc.org © 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Eur. J. Org. Chem. 2012, 3043–30583058
Sharma, P. J. Hrdlicka, Chem. Commun. 2010, 46, 4929–4931.
[77] M. Smietana, R. B. Johnson, Q. M. Wang, E. T. Kool, Chem.
Eur. J. 2004, 10, 173–181.
[78] C. Freeman, A. N. Cheallaigh, F. Heaney, Tetrahedron 2011,
67, 7860–7865.
[79] K. Gutsmiedl, C. T. Wirges, V. Ehmke, T. Carell, Org. Lett.
2009, 11, 2405–2408.
[80] T. Plass, S. Milles, C. Koehler, C. Schultz, E. A. Lemke, Angew.
Chem. Int. Ed. 2011, 50, 3878–3881.
[81] a) I. S. Marks, J. S. Kang, B. T. Jones, K. J. Landmark, A. J.
Cleland, T. A. Taton, Bioconjugate Chem. 2011, 22, 1259–1263;
b) P. v. Delft, N. J. Meeuwenoord, S. Hoogendoorn, J. Dinke-
laar, H. S. Overkleeft, G. A. v. d. Marel, D. V. Filippov, Org.
Lett. 2010, 12, 5486–5489; c) P. van Delft, E. van Schie, N. J.
Meeuwenoord, H. S. Overkleeft, G. A. van der Marel, D. V. Fi-
lippov, Synthesis 2011, 2724–2732.
[82] L. A. Canalle, M. van der Knaap, M. Overhand, J. C. M.
van Hest, Macromol. Rapid Commun. 2011, 32, 203–208.
[83] I. Singh, C. Freeman, F. Heaney, Eur. J. Org. Chem. 2011, 33,
6739–6746.
[84] G. Godeau, C. Staedel, P. Barthelemy, J. Med. Chem. 2008, 51,
4374–4376.
[85] A. Taherpour, E. Rajaeian, THEOCHEM 2008, 849, 23–24.
[86] C. S. McKay, J. Moran, J. P. Pezacki, Chem. Commun. 2010,
46, 931–933.
[87] X. Ning, R. P. Temming, J. Dommerholt, J. Guo, D. B. Ania,
M. F. Debets, M. A. Wolfert, G.-J. Boons, F. L. van Delft, An-
gew. Chem. 2010, 122, 3129; Angew. Chem. Int. Ed. 2010, 49,
3065–3068.
[88] H. Ghosh, B. K. Patel, Org. Biomol. Chem. 2010, 8, 384–390.
[89] I. Singh, F. Heaney, Chem. Commun. 2011, 47, 2706–2708.
[90] J. Gierlich, K. Gutsmiedl, P. M. E. Gramlich, A. Schmidt, G.
Burley, T. Carell, Chem. Eur. J. 2007, 13, 9486–9494.
[91] a) M. Galibert, P. Dumy, D. Boturyn, Angew. Chem. 2009, 121,
2614; Angew. Chem. Int. Ed. 2009, 48, 2576–2579; b) Z. Jia,
C. A. Bell, M. J. Monteiro, Chem. Commun. 2011, 47, 4165–
4167; c) C. A. De Forest, B. D. Polizzotti, K. S. Anseth, Nat.
Mater. 2009, 8, 659–664; d) T. Kang, R. J. Amir, A. Khan, K.
Ohshimizu, J. N. Hunt, K. Sivanandan, M. I. Montañez, M.
Malkoch, M. Ueda, C. J. Hawker, Chem. Commun. 2010, 46,
1556–1558.
[92] K. Kempe, R. Hoogenboom, M. Jaeger, U. S. Schubert, Mac-
romolecules 2011, 44, 6424–6432.
[93] V. Aucagne, D. A. Leigh, Org. Lett. 2006, 8, 4505–4507.
[94] a) K. P. Kaliappan, P. Kalanidhi, S. Mahapatra, Synlett 2009,
2162–2166; b) X. Peng, H. Li, M. Seidman, Eur. J. Org. Chem.
2010, 4194–4197.
[95] a) P. A. Ledin, F. Friscourt, J. Guo, G.-J. Boons, Chem. Eur. J.
2011, 17, 839–846; b) P. Kele, G. Mezo, D. Achatz, O. S. Wolf-
deis, Angew. Chem. 2009, 121, 350; Angew. Chem. Int. Ed. 2009,
48, 344–347.
[96] S. Hilf, A. F. M. Kilbinger, Nature Chem. 2009, 1, 537–546.
[97] R. M. J. Liskamp, D. T. S. Rijkers, R. J. Pieters, A. J. Brouwer,
J. A. F. Joosten EP 1733742 2006, CAN 146:87720.
[98] a) T. Matsumura, F. Ishiwari, Y. Koyama, T. Takata, Org. Lett.
2010, 12, 3828–3831; b) Y.-G. Lee, Y. Koyama, M. Yonekawa,
T. Takata, Macromolecules 2010, 43, 4070–4080.
[99] a) Y. Koyama, M. Yonekawa, T. Takata, Chem. Lett. 2008, 37,
918–919; b) Y.-G. Lee, Y. Koyama, M. Yonekawa, T. Takata,
Macromolecules 2009, 42, 7709–7717; c) Y.-G. Lee, M. Yonek-
awa, Y. Koyama, T. Takata, Chem. Lett. 2010, 39, 420–421.
[100] I. Ito, T. Takada Y. Koyama, JP 2010037289, 2010 CAN
152:262378.
[101] a) I. Singh, Z. Zarafshani, F. Heaney, J.-F. Lutz, Macromole-
cules 2009, 42, 5441–5443; b) I. Singh, Z. Zarafshani, F.
Heaney, J.-F. Lutz, Polym. Chem. 2011, 2, 372–375.
Received: December 19, 2011
Published Online: March 13, 2012
